Growing Diagnostics QuantuMDx is expanding its multiplex molecular diagnostic capabilities with Q-POC rapid PCR solutions, presenting a direct upsell opportunity for on-site testing deployments in healthcare facilities, clinics, and emergency response settings.

Strategic Partnerships Existing distribution partnerships, such as with The Menarini Group, indicate a proven channel strategy that can be leveraged to expand into regional markets and hospital networks requiring validated point-of-care diagnostics.

Awarded Credibility Recent recognition at the Medilink Healthcare Business Awards enhances credibility for sales efforts targeting hospitals and research institutions seeking trusted suppliers of innovative diagnostic tech.

Public Health Focus Q-POC’s capability for rapid infectious disease testing (COVID-19, influenza, RSV, TB partnerships) positions QuantuMDx to pursue bids and tenders for national public health programs, clinics, and outbreak response programs.

Cross-Sector Expertise With a background spanning research, medtech, and microfluidics collaborations (e.g., University of London), there is an opportunity to propose integrated solutions combining diagnostics with data analytics, workflow integration, and training services for healthcare providers.